Harvey RD, Rubinstein WS, Ison G, et al. Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis. ASCO Annual Meeting 2019, abstract LBA108.
Apalutamide verbetert uitkomsten van patiënten met mCSPC die ADT kregen
mei 2021 | Uro-oncologie